Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA
The elimination of tuberculosis (TB) in Europe will require the management of latent tuberculosis infection (LTBI) in key populations. Management of LTBI requires the identification and adequate treatment of infected people. It is currently unknown how screening and treatment of key populations should be best organised to have the highest impact with the available resources.
Preventing blood-borne viruses in prison settings: ECDC and EMCDDA Guidance
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.
Disability weights for infectious diseases in four European countries: comparison between countries and across respondent characteristics.
De Noordhout, C.M., Devleesschauwer, B., Salomon, J.A., Turner, H., Cassini, A., Colzani, E., Speybroeck, N., Polinder, S., Kretzschmar, M.E., Havelaar, A.H., Haagsma, J.A.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA
This report presents the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA: Executive summary
Tuberculosis in the Netherlands
Report of the joint ECDC and WHO review of the tuberculosis prevention and care system in the Netherlands, 24–28 June 2019.